Schedule 13D ownership disclosure

Zivo Bioscience, Inc.

Security class unavailable · CUSIP: 8978N3098

Event date: 2024-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
530,989
Percent of class
15.3400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001618035-24-000005
Form type
SC 13D/A
Filer
HEP INVESTMENTS LLC
CIK
CIK 1618035
Filed
Oct 01, 2024
Reporting period
Jun 28, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub